Background & Aims The effect of hepatocellular carcinoma (HCC) on the response to
interferon-free direct-acting antiviral (DAA) therapy in patients with chronic hepatitis C (CHC) …

Abstract Background Hepatitis C (HCV)-induced decompensated cirrhosis warrants liver
transplantation (LT) as the only ultimate solution. These patients experience liver …

Background Direct‐acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection is
highly curative and tolerable. Among patients with hepatocellular carcinoma (HCC), optimal …

Hepatocellular carcinoma (HCC) is the leading cause of death in patients with cirrhosis. Due
to its poor response to conventional chemotherapy drugs, the prognosis for its survival is the …

Background Previous short-term studies have reported on liver function improvements and
delisting among liver transplantation (LT) candidates with hepatitis C virus (HCV) and …

First and foremost I would like to acknowledge all the people living with hepatitis CI have
met working at the hepatitis outreach clinic in Odense and Svendborg drug treatment center …

Chronic hepatitis B virus (HBV) infection affects approximately 3.5% world population [23],
and is the most common aetiology of hepatocellular carcinoma (HCC). HCC has become …

Цель. Изучить динамику показателей функции печени, портальной гипертензии и
клинические исходы после элиминации вируса гепатита С (HCV) в результате лечения …